Vanda Pharmaceuticals Inc
VNDA
$4.22-1.86%
End of day · as of Oct 14, 2026, 8:00 PM ET
Mkt cap
$358.41M
EV/Sales
1.27
P/E ratio
N/A
FY2025 Revenue
$216.10M
EPS (TTM)
$-4.64
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-102.02%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Latest reported VNDA revenue for 2025-12-31 was $216.1M. Net income was -$220.5M. Revenue was up 8.7% from 2024-12-31 to 2025-12-31. VNDA currently screens at market cap $358.4M.
Use this VNDA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full VNDA income, balance, and cash tables.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company in the Healthcare sector.
Latest cached Vanda Pharmaceuticals Inc (VNDA) revenue for Dec 31, 2025 was $216.1M. Net income was -$220.5M. Statements: https://lician.com/financials/vnda
Vanda Pharmaceuticals Inc (VNDA) market capitalization is $358.4M on the latest cached snapshot.
Vanda Pharmaceuticals Inc (VNDA) cached previous close $4.30; day range $4.21 – $4.29; volume 848,044. Session quote: https://lician.com/quote/vnda
Vanda Pharmaceuticals Inc (VNDA) latest cached earnings event is "VNDA earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached VNDA filing is 8-K · Jan 8, 2026. Filings: https://lician.com/sec/vnda